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Abstract
Lithium carbonate is a drug widely used in Colombia for the treatment of various psychiatric pathologies such as treatment in patients with 
bipolar affective disorder, however its narrow therapeutic index predisposes to the occurrence of acute poisoning, unlikely to happen but 
could be fatal.
It should be said that its diagnosis requires a high rate of suspicion because it presents various clinical manifestations such as neuropsychia-
tric symptoms and even mental disorders of an organic type that can be complicated by an acute kidney injury requiring emergency dialysis 
therapy.
We report the case of a patient who presented to the emergency department with alteration in the state of consciousness in whom lithium 
poisoning was found and who required hemodialysis in an early stage. 
In conclusion, in a patient with risk factor and therapy with this drug is very important to guide appropriate treatment, and also discard 
differential diagnosis, in order to avoid fatal consequences. 
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Resumen
El carbonato de litio es un fármaco ampliamente usado en Colombia para el tratamiento de varias patologías psiquiátricas, como es el caso 
del trastorno afectivo bipolar; sin embargo, su índice terapéutico estrecho predispone a intoxicación aguda. Aunque esta reacción rara vez 
ocurre, puede ser fatal. 
El diagnóstico de intoxicación aguda por carbonato de litio requiere una alta tasa de sospecha, pues se presenta con varias manifestaciones 
como síntomas neuropsiquiátricos e incluso desórdenes mentales, que pueden complicarse por injuria renal aguda requiriendo terapia dia-
lítica emergente. 
A continuación se presenta el caso de una paciente que se llegó al servicio de urgencias con alteración en el estado de conciencia. Finalmente, 
se diagnosticó intoxicación por litio y la mujer requirió hemodiálisis. 
En conclusión, en un paciente con factores de riesgo y terapia con este medicamento es muy importante guiar un manejo apropiado y des-
cartar diagnósticos diferenciales, esto con el fin de evitar consecuencias fatales. 
Palabras clave: diálisis, intoxicación; litio, enfermedad renal crónica, resultado fatal, enfermedades de la vejiga urinaria.
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Introduction
Lithium is a chemical element located in group one (alkali metal) of the periodic table. This specific location enables it to 
ionize into a cation and easily interact with other 
functional groups. In addition, it is the lightest 
metal (74 Daltons), making it easy to be distributed 
throughout the body1 . It’s use in the treatment of 
mental disorders began in 1948 by Doctor John 
Cade in Australia2 . Since then, lithium salts were 
classified as mood stabilizers due to its positive 
empiric impact on the treatment of bipolar affective 
disorders with a success rate of 80% in the treatment 
of both maniac and depressive symptoms3 ,4 .
Case report
A 77 year old woman, with personal history 
of affective bipolar disorder in treatment with 
lithium, presented into our hospital with functional 
declination, somnolence, fever and tremor, for 5 days 
approximately . The physical examination showed 
altered consciousness state, normal blood pressure, 
tachycardia, tachypnea, grade II dehydration, neck 
rigidity, tremor and hyperreflexia with clonus. The 
rest was normal. 
Because the hospital was of first level, basic 
laboratories were available, so initially there was 
focus like meningitis, so antibiotics are started 
after blood and urine samples were collected. 
We observed leukocytosis with neutrophilia, 
altered renal function with GFR in 27.08 ml/
min/1.73 m2 with MDRD formula (figure 1), 
proteinuria, hematuria and massive bacteriuria in 
the urine sediment. Also glycemic levels and an 
electrocardiogram were realized, finding in the 
last one sinus tachycardia, normal ventricular axis, 
interval PR of 180 milliseconds, but a corrected 
interval QT of 510 milliseconds.
In this moment, with these findings, acute lithium 
intoxication was suspected associated with acute 
kidney injury and urinary tract infection, considered 
like an emergency dialysis. Immediately the patient 
was translated to a hospital with the service of 
nephrology and dialysis, and realized serum lithium 
levels finding an abnormal value of 2.85 mmol/L 
(Figure 1) (normal value 0.6 – 1.2 mmol/L). So, 
it was decided to initiate dialysis femoral via and 
antibiotic, presenting good response. In urine 
culture was isolated Proteus Mirabilis, so regimen 
antibiotic with Aztreonam was gave during 10 days 
with resolution of the infection. 
After three days of treatment, renal function and 
serum lithium level were normal. 
Figure 1. Laboratories
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Discussion 
Lithium distribution volume ranges between 
0.6-0.9 L/Kg in the average adult. It has no protein 
or tissue binding, making it a substance with a 
therapeutic index that ranges between 0.6-1.5 
mEq/L, which is very narrow3 . Particularly, the 
optimal steady-state concentration of lithium for 
treatment of bipolar disorders is 0.6-1.2 mEq/L. 
Lithium acts with inositol and glycogen synthase 
kinase 3, by inhibiting an enzyme called inositol 
monophosphatase, decreasing inositol levels and 
altering first and second messenger system. With the 
chronic administration, stabilize GABA reuptake, 
explaining the effect on mania. Also antagonize 
5HT1A and 5HT1B receptors, increasing levels 
of serotonin, explaining the effect on depression 
symptoms. Maintaining these exact ranges may be 
challenging and chances of toxicity remain high. 
Lithium is excreted in its vast majority by the 
kidneys and because of its chemical resemblance to 
sodium; they are handled in a very similar way. It 
is freely filtered and 60% of it is reabsorbed in the 
proximal tubule5 . Due to its high rate of reabsorption 
and distribution throughout the body, lithium´s half-
life may be as high as 18 and 36 hours in the adult 
and the elderly, respectively5 .
As explained in the pharmacokinetics section, 
lithium has several biological interactions that may 
lead to lithium toxicity. The average patient on 
chronic lithium treatment may experience at least 
one episode of toxicity during his lifetime6 . Lithium 
toxicity is classified by most authors in three different 
types: Acute, which includes manifestations 
that are predominantly gastrointestinal, such as 
nausea, vomiting and diarrhea, but neuromuscular 
manifestations may also be present; Acute on 
chronic, in which both gastrointestinal and 
neurologic manifestations occur; and Chronic that 
includes manifestations primarily neurological, 
including sluggishness, ataxia and neuromuscular 
excitability7 . 
Toxicity is explained mostly by abnormally 
reduced excretion in the kidneys, overdose, 
prescribing errors and drug-to-drug interactions. 
Lithium has no protein or tissue binding, therefore, 
hemodialysis provides a useful therapeutic strategy8 .
At the intracellular level, lithium ion is transported 
from the lumen to the intracellular space by different 
protein channels, by means of an exchanging cation 
pump, in substitution of either sodium or potassium. 
The H+/Na+ exchanger accounts for most of the 
lithium transported into the cytosol and posteriorly 
to the blood. Particularly, lithium entrance is 
handled by passive transports compared to its 
exit, which is handled by pumps involving active 
transport and energy use. Secondary to this pump 
imbalance, lithium tends to accumulate throughout 
the body: Other channels might also contribute to 
the accumulation of Lithium, such as Glucose/Na 
channel or Na/K ATPase9 .
Back to our patient: Our patient developed 
an urinary tract infection (UTI), particularly a 
pyelonephritis, as manifested by its systemic 
symptoms, clinical findings and urinalysis findings. 
According to classification criteria, our patient 
met criteria urosepsis etiology. Its urine culture 
was found to be positive for Proteus Mirabilis, a 
facultative anaerobe bacteria, urease positive with 
increasing rates of antibiotics resistance10 . Because 
of the pyelonephritis, induced renal impairment 
manifested as reduced GFR and an increased 
reabsorption (secondary to its sepsis induced 
vasodilation and dehydration), leading to increased 
lithium levels up to 2.85 mEq/L. 
The main stem for treatment of acute lithium 
toxicity relies on following the ABC protocols 
(Airway, Breath, Circulation) and supportive 
care, followed by aggressive hydration in order to 
guarantee appropriate lithium clearance. Hydration 
should be done with normal saline (0.9%). Sodium 
levels should be assessed prior to treatment because 
these patients may develop induced nephrogenic 
diabetes insipidus, which makes it important to 
have a baseline serum sodium level upon hydration. 
Treatment with oral charcoal is not recommended by 
most authors11 . Some studies have shown a benefit 
of giving high doses of kayexelate (oral sodium 
polystyrene sulfonate) is reducing lithium levels, 
however, its use is not recommended secondary 
to the side effects of hypokalemia12 . Ultimately, 
the gold standard treatment when these therapies 
fail is the use of hemodialysis as an extracorporeal 
measure. Consensus guidelines for the use of 
hemodialysis in this setting are controversial. Some 
authors suggest using hemodialysis in patients with 
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lithium levels greater than 5 mEq/L and a normal 
renal function. In those with impaired renal function 
(creatinine higher than 2 mmol/L) and lithium 
levels of 4 mEq/L, therapy can be considered as 
well13 . Finally, those patients who don´t respond to 
previous treatment and in whom signs of toxicity 
persist, hemodialysis remains as a reasonable option. 
More studies are needed to provide guidelines with 
a stronger degree of recommendation14 .
In our patient, the lithium levels quickly fell after 
hemodialysis, from 2.85 to 0.89 mEq/L in a 24-hour 
period. Additionally, the BUN and creatinine levels 
also fell down to normal after the prerenal acute 
kidney injury was solved. Creatinine and BUN 
decreased from 1.89 to 0.85mg/dl and from 43 to 
17mg/dl respectively, in a 48-hour period.
Conclusion
Patients treated for bipolar affective disorder 
with lithium must be specifically warned on 
how to early identify possible triggers that may 
induce acute kidney injury, such as UTI, systemic 
infections, volume depletion states patients must 
stop medication and seek medical care.
Detailed clinical history of patients initial 
neurological disorders before initiating Lithium 
therapy is required, since lithium intoxication 
symptoms tend to be mostly neurological, so there 
must be a clear differentiation between the treated 
pathology symptoms and the newly acquired 
intoxication symptoms for the diagnosis to be 
possible and timely. In this case, there were three 
potential triggers for the GFR drop: Pyelonephritis, 
prerenal acute kidney injury and prolonged lithium 
exposure. The summation of these caused Lithium 
serum levels to increase to toxic levels and resulted 
in an intoxication, however, the dehydration had the 
most evident repercussions. 
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